pr-inside.com
Print

GenScript Launches New PolyExpress Package



2013-02-01 10:26:24 - With the completion of an extensive new animal facility and validation of ground-breaking new immunization protocols, GenScript is able to offer this new antibody package at a staggeringly fast delivery time of just 45 days, 2 months faster than traditional immunization methods.

PISCATAWAY, NJ, Jan. 31, 2013–As a compliment to their successful MonoExpressTM package, GenScript USA Incorporation has launched a new guaranteed PolyExpressTM pAb Service package.

As a major upgrade to GenScript’s Express Complete Affinity-Purified Peptide Polyclonal Antibody Package, the new PolyExpressTM package offers a series of exciting advantages to their customers. With the completion of an extensive new animal facility and

validation of ground-breaking new immunization protocols, GenScript is able to offer this new package at a staggeringly fast delivery time of just 45 days, 2 months faster than traditional immunization methods. The recent increase in pAb production capacity allows GenScript to guarantee 1-5 mg of affinity purified antibody with PolyExpressTM at the lowest cost on the market. Speed and affordability don’t mean a loss in quality, and GenScript both guarantees a final ELISA titer of at least 1:32,000 and provides full quality reports with every delivery. This upgrade offers free bundling of essential services including peptide design, carrier conjugation and purification making this a one stop service package ideal to accelerate their customers’ research.

GenScript
GenScript offers a full spectrum of human antibody services, including target screening and expression, immunization, monoclonal antibody screening at any desired high complexity, antibody sequencing and characterization, biological and other assays, antibody production cell line development, model animal-based efficacy studies and more. GenScript's antibody development team consists of senior scientists and business managers who have extensive experience in therapeutic antibody development. They have been involved in the full process of therapeutic drug development. GenScript has already successfully gained a top position in gene synthesis worldwide, and has established leading positions in many other biology service areas.

To learn more about this exciting new opportunity, visit www.genscript.com/PolyExpress.html today or contact your local customer service representative.

# # # #

For further information, please contact:
Sally Wang
Executive Vice President
GENSCRIPT USA Inc.
sallyw@genscript.com
1-(732) 885-9188

Source: www.genscript.com

Contact Information:
GenScript USA Inc.

860 Centennial Ave.
Piscataway, NJ 08854
USA

Contact Person:
Genscript

Phone: 1-(732) 885-9188
email: e-mail

Web: http://www.genscript.com



Author:
kathy kathyli
e-mail
Web: http://www.genscript.com/
Telefon: 18774367274




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.